OptEd Archives

Pharma sees GLP-1 receptor agonists as a way to make huge profits. Once developed for Type 2 diabetes, they’ve evolved into the hottest category in weight management. The numbers are …

As I See It / OptEd / Patients Voice

Is Our Healthcare System Too Far Gone To Fix?

February 5, 2025February 5, 2025 - Leave a Comment

There was a time when I loved being a pharmaceutical marketer because, in focus groups, I heard how people relied on the drugs we sold to help them live better …